We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.3B
AUM Growth
-$438M
Cap. Flow
-$385M
Cap. Flow %
-5.28%
Top 10 Hldgs %
23.31%
Holding
3,320
New
46
Increased
2,165
Reduced
525
Closed
74

Top Sells

Rank Stock Value
1
NDAQ icon
Nasdaq
NDAQ
+$90.2M
2
AFL icon
Aflac
AFL
+$85.3M
3
HSY icon
Hershey
HSY
+$53.5M
4
JNJ icon
Johnson & Johnson
JNJ
+$48.8M
5
ABBV icon
AbbVie
ABBV
+$46.6M

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Financials 18.4%
3 Healthcare 12.02%
4 Consumer Discretionary 8.91%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBIO icon
2726
Orchestra BioMed
OBIO
$267M
$1.85K ﹤0.01%
462
+409
+772% +$2.2K
XMTR icon
2727
Xometry
XMTR
$5.19B
$1.83K ﹤0.01%
43
AVDX
2728
DELISTED
AvidXchange
AVDX
$1.83K ﹤0.01%
177
LXRX icon
2729
Lexicon Pharmaceuticals
LXRX
$1.07B
$1.83K ﹤0.01%
2,477
+2,205
+811% +$2.66K
TGLS icon
2730
Tecnoglass Holdings Inc.
TGLS
$1.84B
$1.82K ﹤0.01%
23
WWW icon
2731
Wolverine World Wide
WWW
$1.55B
$1.82K ﹤0.01%
82
LIF
2732
Life360
LIF
$5.24B
$1.82K ﹤0.01%
44
+35
+389% +$1.54K
ARCT icon
2733
Arcturus Therapeutics
ARCT
$200M
$1.78K ﹤0.01%
105
+76
+262% +$1.43K
INNV icon
2734
InnovAge Holding
INNV
$1.48B
$1.77K ﹤0.01%
451
+404
+860% +$2.09K
APGE icon
2735
Apogee Therapeutics
APGE
$10.2B
$1.77K ﹤0.01%
39
+2
+5% +$102
DSGR icon
2736
Distribution Solutions Group
DSGR
$1.61B
$1.75K ﹤0.01%
51
+37
+264% +$1.42K
HLVX
2737
DELISTED
HilleVax
HLVX
$1.75K ﹤0.01%
847
+760
+874% +$1.43K
SWKH
2738
DELISTED
SWK Holdings
SWKH
$1.75K ﹤0.01%
139
+125
+893% +$1.63K
CRMD icon
2739
CorMedix
CRMD
$591M
$1.72K ﹤0.01%
212
+147
+226% +$1.47K
BFS
2740
Saul Centers
BFS
$839M
$1.71K ﹤0.01%
44
+31
+238% +$1.24K
AGEN
2741
Agenus
AGEN
$291M
$1.7K ﹤0.01%
622
+563
+954% +$2.08K
CRBP icon
2742
Corbus Pharmaceuticals
CRBP
$177M
$1.7K ﹤0.01%
144
+125
+658% +$2.1K
RACE icon
2743
Ferrari
RACE
$71.5B
$1.7K ﹤0.01%
4
-310
-99% -$140K
ACHV icon
2744
Achieve Life Sciences
ACHV
$685M
$1.7K ﹤0.01%
482
+418
+653% +$1.89K
CLYM
2745
Climb Bio
CLYM
$778M
$1.69K ﹤0.01%
941
+829
+740% +$3K
RXRX icon
2746
Recursion Pharmaceuticals
RXRX
$1.76B
$1.69K ﹤0.01%
250
+12
+5% +$81
FHTX icon
2747
Foghorn Therapeutics
FHTX
$371M
$1.67K ﹤0.01%
354
+306
+638% +$2.23K
ASAN icon
2748
Asana
ASAN
$2.13B
$1.66K ﹤0.01%
82
+2
+3% +$32
JOE icon
2749
St. Joe Company
JOE
$3.77B
$1.66K ﹤0.01%
37
PD icon
2750
PagerDuty
PD
$916M
$1.66K ﹤0.01%
91
+1
+1% +$19

Similar funds

Sterling Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Sterling Capital Management held 3,320 positions worth $7.3B, down 5.7% from $7.74B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Sterling Capital Management withdrew a net $385M in Q4 2024, closing 74 positions and reducing 525 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $4.12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Sterling Capital Management opened a new position in iShares Russell 1000 Value ETF worth $10.5M.

  • Sterling Capital Management's largest Q4 2024 buy was iShares Russell 1000 Value ETF: 56,923 shares worth $10.5M.
  • Sterling Capital Management added most to Everest Group in Q4 2024, an estimated $103M increase.
  • Sterling Capital Management's biggest Q4 2024 reduction was Nasdaq, cutting an estimated $90.2M.
  • Sterling Capital Management fully exited iShares Russell 1000 Growth ETF in Q4 2024, selling an estimated $4.12M.
  • Sterling Capital Management's ten largest holdings make up 23% of its $7.3B portfolio in Q4 2024.
  • Sterling Capital Management opened 46 new positions and closed 74 in Q4 2024.
  • Sterling Capital Management's portfolio value fell 5.7% quarter-over-quarter to $7.3B.

Based on Sterling Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.